Stanley Druckenmiller Reata Pharmaceuticals, Inc. Class A

Avg closing price

Price range

Increased shares by 24.6% (+105 Thousand shares) Q1 2020

$193.06

$124.16 - $247.74

New holding (+173 Thousand shares) Q3 2019

$84.86

$71.26 - $95.75

Increased shares by 146.3% (+253 Thousand shares) Q4 2019

$182.82

$74.57 - $217.92

Increased shares by 0.2% (+1 Thousand shares) Q2 2020

$152.02

$126.30 - $176.56

Increased shares by 2.1% (+11 Thousand shares) Q3 2020

$124.95

$93.53 - $163.34